Please login to the form below

Not currently logged in
Email:
Password:

Eisai to share clinical trial data via external website

Company aims to further promote transparency in the industry

EISAI 

Japanese pharma firm Eisai has revealed its policy on clinical trial data disclosure by making its data publicly available to researchers via an external website.

Eisai's Policy on Clinical Trial Data Access and the Disclosure of Clinical Trial Information has been published on the company's website and strives to further promote transparency. 

Eisai has also committed to publishing the results of phase III clinical trials in scientific literature or by poster or oral presentation at scientific meetings as well as results of significant medical importance irrespective of the nature of the outcomes.

The firm believes that transparency will lead to the advancement of science and medicine, aiming to contribute to the improvement of public health. 

The external website, clinicalstudydatarequest.com, was established to enable researchers to utilise clinical trial data in their research to further boost this objective. Researchers can submit a request via the site, which is then reviewed by an independent panel. If approved, Eisai will then provide researchers with rights to access with anonymised clinical trial data.

Data will be shared for clinical trials for products submitted and approved after January 1 2014 in Europe and the US.

Eisai is forthcoming in its approach to digital outreach, this year setting up an online community of personal weight loss stories as part of its marketing efforts for obesity brand Belviq.

Article by
Kirstie Pickering

26th May 2015

From: Research, Regulatory

Share

Tags

Related Hub content

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics